International Council of Nurses representing nursing at the World Health Organization: COVID-19, policy and holding politicians to account.

COVID-19 COVID-19 deaths International Council of Nurses World Health Assembly World Health Organization health policy health workers mortality nursing deaths nursing policy

Journal

International nursing review
ISSN: 1466-7657
Titre abrégé: Int Nurs Rev
Pays: England
ID NLM: 7808754

Informations de publication

Date de publication:
Sep 2021
Historique:
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 26 11 2021
Statut: ppublish

Résumé

The International Council of Nurses is in a unique position to represent nurses at the World Health Organization, and its task has never been more urgent than this year. Amid the global COVID-19 pandemic, the death rates of nurses and other health care workers are truly shocking, with around 115 000 deaths. However, many countries do not collect statistics on health and care workers' deaths and infections from COVID-19, so the full extent of this awful situation is not known. At this year's World Health Assembly, the body that sets the World Health Organization's agenda for the following year, the International Council of Nurses' 50-strong delegation voiced the concerns of nurses and ensured that the views and advice of nurses were heard by the World Health Organization's 194 member states' delegates. Here, the International Council of Nurses' Chief Executive Officer Howard Catton describes how the Council is influencing health and care policy worldwide. He urges nurses everywhere to hold their politicians to account.

Identifiants

pubmed: 34551116
doi: 10.1111/inr.12702
pmc: PMC8652658
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-269

Informations de copyright

© 2021 International Council of Nurses.

Références

Int Nurs Rev. 2021 Sep;68(3):267-269
pubmed: 34551116

Auteurs

Howard Catton (H)

International Council of Nurses, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH